Approved Study Database
| Ref. No. | Scientific Title | Principal investigator |
|---|---|---|
| 2015.011 | Precision Diagnosis of Intracranial Atherosclerosis by Using High resolution MRI: Plaque Morphology and/or Components rather than Arterial Stenosis Predict Stroke Recurrence | Prof. CHEN Xiangyan |
| 2013.404 | The effects of plaque morphology and endothelial function on cerebral artery reactivity in post-mortem cases | Prof. CHEN Xiangyan |
| 2017.022 | Identification of vulnerable intracranial plaques of high thromboembolic potential: a longitudinal study combining high-resolution MR plaque imaging and transcranial Doppler |
Prof. CHEN Xiangyan 陳向燕 |
| 2016.310 | Quantitatively-assessed intracranial arterial calcification predicts stroke prognosis and recurrent ischemic events: a retrospective study based on stroke registry | Dr. CHEN Xiangyan |
| 2019.277 | Endometrial leucocytes around the time of embryo implantation in women undergoing in vitro fertilization- embryo transfer (IVF-ET) | Dr. CHEN Xiaoyan |
| 2019.354 | Do women with a history of recurrent miscarriage have a higher risk of obstetric and perinatal complications in a subsequent pregnancy? A cohort study. | Dr. CHEN Xiaoyan |
| 2018.365 | Do endometrial leucocytes and angiogenesis in the peri-implantation period predict hypertensive disorders in the subsequent pregnancy? | Dr. CHEN Xiaoyan |
| 2025.612 | A pilot experimental study of acoustic stimulation in enhancing slow wave sleep to improve sleep quality in insomnia disorder |
Dr CHEN XIE 陈勰 |
| 2024.108 | Genomic identification of ferroptosis-associated circRNAs in pancreatic ductal adenocarcinoma and functional characterization in tumor immune microenvironment |
Prof. CHEN Yang Chao Yangchao Chen |
| 2022.077 | Investigation of circRNA-lncRNA interaction as the novel gene regulation mechanism of circGANAB in pancreatic ductal adenocarcinoma |
Prof. CHEN Yang Chao 陳揚超 |
| 2012.142 | Regulation and function of histone demethylase JMJD3 in HBV-induced hepatocarcinogenesis | DR CHEN YANG CHAO |
| 2012.141 | Functional characterization of histonr H3 lysine 27 demethylase JMJD3 in Pancreatic Ductal Adenocarcinoma | DR CHEN Yang Chao |
| 2010.178 | Regulation of miroRNA-34a expression by EZH2 in pancreatic ductal adenocarcinoma | Dr. Chen Yangchao |
| 2009.138 | Regulation of S100P expression by IL-6 pancreatic ductal adenocarcinoma | Dr. Chen Yangchao |
| 2010.593 | Functional characterization of EZH2/microRNA-218 interaction in pancreatic ductal adenocarcinoma | DR Chen Yangchao |
| 2013.163 | Identification and functional characterization of long non-coding RNAs associated with pancreatic ductal adenocarcinoma | Dr Chen Yangchao |
| 2009.136 | Role of Beta-arrestin in HIV infection and heroin addiction | Dr. Chen Yangchao |
| 2017.232 | Genome-wide identification of circular RNAs with critical roles in pancreatic ductal adenocarcinoma |
Dr. CHEN Yangchao 陳揚超 |
| 2016.217 | Identification of Novel Tumor Suppressor Long Non-coding RNAs epigenetically silenced in Hepatocellular Carcinoma |
Dr. CHEN Yangchao 陳揚超 |
| 2010.196 | Development of HPV therapeutic vaccine and related immunotherapy for treating cervical cancer | DR Chen Yangchao |
| 2021.508 | The investigation of anti-tumor activity of novel bispecific antibodies against solid tumors |
Dr. CHEN Yangchao 陳揚超 |
| 2020.042 | Elucidating the novel mechanisms of the oncogenic circRNA-DNA interactions and investigating their roles in pancreatic ductal adenocarcinoma |
Dr. CHEN Yangchao 陳揚超 |
| 2018.124 | Identification of novel therapeutic target kinase for KRAS mutant pancreatic ductal adenocarcinoma by kinome-wide RNAi screening |
Dr. CHEN Yangchao 陳揚超 |
| 2019.098 | Characterization of the anti-metastatic function of POU4F3 in pancreatic ductal adenocarcinoma and delineate its underlying mechanisms |
Dr. CHEN Yangchao 陳揚超 |
| 2023.673 | Effect of A Self-Regulation Promoting Education Program on Adherence to Oral Anticancer Agents among Patients with Gastrointestinal Tract Cancer: A Randomized Controlled Trial |
Ms. CHEN Yongfeng 陈永凤 |
| 2016.556 | Quantification of breast milk trans fatty acids and trans fat intake by Hong Kong lactating women |
Dr. CHEN Zhen Yu 陳振宇 |
| 2017.143 | Association between oral microbiome, HPV and human epigenetic events in head and neck squamous cell carcinoma | Prof. CHEN Zigui |
| 2016.186 | Evolutionary dynamics and genetic basis of carcinogenicity of primate papillomaviruses | Prof. CHEN Zigui |
| 2023.637 | Understanding the Role of Oral Microbiota Dysbiosis in the Pathogenesis of Oral Cavity Squamous Cell Carcinoma (OSCC) through Dysregulation of Epithelial-Mesenchymal Transition (EMT)-related Pathways |
Prof. CHEN Zigui 陳子桂 |
| 2025.016 | Unravelling the Impact of Oral Microbiota Dysbiosis and HPV on Genomic Architecture and Tumor-Associated Immune System in Oropharyngeal Squamous Cell Carcinoma (OPSCC) |
Prof. CHEN Zigui 陳子桂 |
| 2025.683 | Unravelling the crosstalk between oral microbiota dysbiosis and immune checkpoint dysregulation in head and neck squamous cell carcinoma (HNSCC) patients: towards personalized immunotherapy | Prof. Chen Zigui |
| 2026.006 | Understanding Microbiota-Guided Remodeling of OSCC Immune Microenvironment: from Dysbiosis to ICI Sensitization | Prof. CHEN Zigui |
| 2025.677 | 微生物菌群调控食管鳞状细胞癌免疫治疗的增敏机制与转化研究 (Mechanism and Application of Microbiota-Modulated Immunotherapy for Esophageal Squamous Cell Carcinoma (ESCC)) | Prof. CHEN Zigui |
| 2018.022 | Structure and diversity of gastrointestinal (oral and stool) microbial communities of companion animals impacting on human counterparts |
Prof. CHEN Zigui 陳子桂 |
| 2019.036 | Dissecting the role of Fusobacterium nucleatum in head and neck squamous cell carcinoma by genomics and functional approaches |
Prof. CHEN Zigui 陳子桂 |
| 2020.001 | Genomic and Functional Characterization of Oral Microbiome Associated with Head and Neck Squamous Cell Carcinoma |
Prof. CHEN Zigui 陳子桂 |
| 2021.671 | Characterization of Genomic and Functional Features of Human Microbiome Associated with Oral Cavity Squamous Cell Carcinoma using Multi-Omics Approaches |
Prof. CHEN Zigui 陳子桂 |
| 2020.705 | Associations between human microbiome and host epigenetic and genetic events in esophageal squamous cell carcinoma (ESCC) using multi-omics approaches |
Prof. CHEN Zigui 陳 子 桂 |
| 2022.553 | Genetic and Epigenetic Abnormalities Associated with Dysbiosis of the Human Microbiota in Esophageal Squamous Cell Carcinoma (ESCC) |
Prof. CHEN Zigui 陳子桂 |
| 2021.681 | Origin and evolutionary adaptation of the carcinogenicity of human papillomaviruses: evaluation of human and non-human primate PV E6 and E7 oncogenes interacting with host proteomes |
Prof. CHEN Zigui 陳子桂 |
| 2022.554 | Host-Microbiota Interactions Related to HPV(+) and HPV(-) Oropharyngeal Squamous Cell Carcinoma (OPSCC) |
Prof. CHEN Zigui 陳子桂 |
| 2019.276 | To develop an evidence-based training programme for improving infection control knowledge and skills related to multi-drug resistance organisms (MDROs) transmission during enteral feeding among hospital nurses. |
Miss CHENG Wai Yan 鄭慧恩 |
| 2018.051 | Functional dissection of fibrosis-associated monocytic myeloid derived suppressor cells (M-MDSCs) in hepatocellular carcinoma |
Prof. CHENG Alfred Sze Lok 鄭詩樂 |
| 2018.576 | Molecular and functional characterization of the immunoregulatory CCRK-mTOR pathway in NAFLD-associated hepatocellular carcinoma |
Prof. CHENG Alfred Sze Lok 鄭詩樂 |
| 2018.411 | Deciphering Enhancer Regulation of Tumor Immune Evasion to Develop New Combination Immunotherapies |
Prof. CHENG Alfred Sze Lok 鄭詩樂 |
| 2015.187 | Dissecting an inflarnmatory-CCRK circuitry m non-alcoholic fatty liver disease-related hepatocarcinogenesis |
Prof. CHENG Alfred Sze Lok 鄭詩樂 |
| 2014.076 | Mechanistic characterization of liver cancer epigenome mediated by androgen receptor signaling | Dr. CHENG Alfred Sze Lok |
| 2016.230 | Co-targeting the AKT and EZH2 epigenetic pathways in hepatitis B virus-related hepatocellular carcinoma |
Prof. CHENG Alfred Sze Lok 鄭詩樂 |
| 2023.105 | The role of macrophage lipid transfer in driving immunotherapy resistance of hepatocellular carcinoma cells | Prof. CHENG Alfred Sze Lok |
| 2021.227 | Advancing Precision Immunotherapy of Hepatocellular Carcinoma by Single-cell Multi-Omics |
Prof. CHENG Alfred Sze Lok 鄭詩樂 |
Page 72 of 288.